PATENT CLAIM ANALYSIS

Application Number: 16179896
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-10
Patent Classification: ["514", "728000"]

Abstract:
Disclosed herein are methods for treating conditions and/or disorders related to hyperglycemia. Such conditions and/or disorders related to hyperglycemia include, but are not limited to, type I, II diabetes mellitus, gestational diabetes, other forms diabetes, and disorders related thereto. In particular, the present invention relates to methods of using (R)-(+)-verapamil or a pharmaceutically acceptable salt thereof and an α-glycosidase inhibitor in the treatment of conditions and/or disorders related to hyperglycemia.

Claim (Index 8):
The pharmaceutical composition of  claim 7 , wherein the (R)-(+)-verapamil or a pharmaceutically acceptable salt thereof is present in the pharmaceutical composition in the amount of 15 to 1,000 mg; and the \u03b1-glycosidase inhibitor is present in the pharmaceutical composition in the amount of 10 to 1,000 mg.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 98.0
- Lexical Diversity: 1.61111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15957956', '15597200', '12560292', '12673327', '14326075']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7146080945240608
- 35 USC 102 Novelty (BERT): 0.5525845489342732
- Combined Prediction Score: 0.698405739965082
- Mean Citation Score: 310.39375600000005
- Max Citation Score: 399.34293
- Similarity Product: 300.4666364690423

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test